Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Laboratory Corporation of America Holdings    LH

LABORATORY CORPORATION OF AMERICA HOLDIN

(LH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/27/2020 07/28/2020 07/29/2020 07/30/2020 07/31/2020 Date
201.3(c) 196.54(c) 194.61(c) 194.84(c) 192.92(c) Last
903 266 1 436 702 1 036 266 750 325 640 071 Volume
+1.29% -2.36% -0.98% +0.12% -0.99% Change
More quotes
Financials (USD)
Sales 2020 12 647 M - -
Net income 2020 854 M - -
Net Debt 2020 4 884 M - -
P/E ratio 2020 22,1x
Yield 2020 -
Sales 2021 12 937 M - -
Net income 2021 1 084 M - -
Net Debt 2021 4 179 M - -
P/E ratio 2021 17,3x
Yield 2021 -
Capitalization 18 771 M 18 771 M -
EV / Sales 2020 1,87x
EV / Sales 2021 1,77x
Nbr of Employees 65 000
Free-Float 99,3%
More Financials
Company
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - supply of testing services (59.5%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - supply of genomic and esoteric testing services (40.5%). Net sales are distributed geographically as follows : the... 
More about the company
Surperformance© ratings of Laboratory Corporation of
Trading Rating : Investor Rating :
More Ratings
Latest news on LABORATORY CORPORATION OF
08:46aLABORATORY OF AMERICA : HHS Details Multiple COVID-19 Testing Statistics as Nati..
AQ
07/31LABORATORY OF AMERICA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
07/30LABCORP : Working With Public Health Authorities on No-Charge Antibody Test Prog..
BU
07/28Pandemic Boosts Sales of Lysol, N95 Masks -- Earnings at a Glance
DJ
07/28LABCORP : 2Q Earnings Snapshot
AQ
07/28LABCORP : Announces 2020 Second Quarter Results
BU
07/27LABORATORY OF AMERICA : LabCorp Receives Authorization for COVID-19 Sample Pooli..
AQ
07/27LABORATORY OF AMERICA : Coronavirus Update, FDA Authorizes First Diagnostic Test..
AQ
07/25LABCORP : Receives Authorization for COVID-19 Sample Pooling
BU
07/23Quest medical lab sees COVID-19 test speed at 'acceptable' level by Sept
RE
07/23LABORATORY CORPORATION OF AMERICA HO : half-yearly earnings release
07/23LABORATORY OF AMERICA : JLL and LabCorp team up to enable safer healthier workpl..
AQ
07/10LABORATORY OF AMERICA : LabCorp's Insight Analytics Reports Help Healthcare Orga..
AQ
07/09LABCORP : 's Insight Analytics Reports Help Healthcare Organizations Identify Tr..
BU
07/09Wait Times Grow for Covid-19 Test Results as Infections Rise Sharply
DJ
More news
News in other languages on LABORATORY CORPORATION OF
08:46aLABORATORY OF AMERICA : HHS Details Multiple COVID-19 Testing Statistics as Nati..
07/31LABORATORY OF AMERICA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
07/30LABCORP : Working With Public Health Authorities on No-Charge Antibody Test Prog..
07/28Pandemic Boosts Sales of Lysol, N95 Masks -- Earnings at a Glance
07/28LABCORP : 2Q Earnings Snapshot
More news
Chart LABORATORY CORPORATION OF AMERICA HOLDINGS
Duration : Period :
Laboratory Corporation of America Holdings Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABORATORY CORPORATION OF
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 224,88 $
Last Close Price 192,92 $
Spread / Highest target 29,1%
Spread / Average Target 16,6%
Spread / Lowest Target -5,14%
EPS Revisions
Managers
NameTitle
Adam H. Schechter President, Chief Executive Officer & Director
David P. King Chairman
Glenn Andrew Eisenberg Chief Financial Officer, Treasurer & Executive VP
Lance V. Berberian Chief Information Officer & Senior Vice President
Brian J. Caveney Chief Medical Officer, EVP & President-Diagnostics
Sector and Competitors